ICD-10 · PDGM grouping
D60 Acquired pure red cell aplasia [erythroblastopenia]
All 4 codes in the D60 family, with the PDGM clinical group, comorbidity subgroup and primary-position rule CMS assigns, read from the CMS grouper crosswalk v07.2.26 and the CDC FY2027 code file.
Codes in family
4
Can lead a claim
4
Cannot lead a claim
0
What CMS assigns to D60
All 4 codes group to MMTA - Infectious Disease, Neoplasms, and Blood-Forming Diseases. All 4 count toward the Hemolytic, Aplastic, and Other Anemias comorbidity subgroup. Every code can lead a claim.
- Hemolytic, Aplastic, and Other Anemias: can award the low comorbidity tier as a secondary diagnosis.
Every code in D60
Descriptions are CDC’s FY2027 wording; where CMS’s grouper abbreviates one, its form is shown beneath.
| Code | Description | Primary position | Clinical group | Comorbidity subgroup |
|---|---|---|---|---|
| D60.0 | Chronic acquired pure red cell aplasia | Can lead a claim | K | Hemolytic, Aplastic, and Other Anemias |
| D60.1 | Transient acquired pure red cell aplasia | Can lead a claim | K | Hemolytic, Aplastic, and Other Anemias |
| D60.8 | Other acquired pure red cell aplasias | Can lead a claim | K | Hemolytic, Aplastic, and Other Anemias |
| D60.9 | Acquired pure red cell aplasia, unspecified | Can lead a claim | K | Hemolytic, Aplastic, and Other Anemias |
Sources: CMS HH PPS Grouper Software v07.2.26, effective 2026-10-01, for the clinical group, comorbidity subgroup, code-first conventions and primary-position flags; CDC NCHS ICD-10-CM FY2027 code descriptions for the family title and code wording. This is the crosswalk Medicare runs a claim through. Grouping also depends on admission source, timing, the OASIS functional items and the rest of the diagnosis list.
The monthly home health regs digest
What CMS changed, what's due next, and what to do about it — one email a month, no fluff. Read the first issue